Genmab — Juli 2020
-
Alle jer ferierende chatdeltagere kan vist godt sætte vin på campingbordet i aften. Aktiekursen er ikke sådan at holde nede på grund af et salgstal som umiddelbart er under forventningerne.
-
En imponerende slutspurt den satte ind:-D
-
Er ikke slut endnu.
-
2328 - dagens højeste. 56.000 stk igennem slutauktionen.
-
Den fik den lige presset spurten til 2328.
-
Sorry. Det var 36.000 stk som røg i slutauktionen.
-
Dejlig afslutning på ugen. Go´weekend:-)
-
I lige måde.
-
Snød på stregen og drak cremant med mrs. nohope i boblebadet i går aftes - mens solen gik ned i horisonten. https://easyupload.io/u28tqr
-
Håbet lever...nohope..dejligt billede.
-
Could the clinical application of selinexor, a first-in-class XPO1
inhibitor, be extended to triplet regimens for the treatment of RRMM? Selinexor plus Dara+d, Kd, or Vd (BOSTON trial). Read a summary of the updates from Asco. https://multiplemyelomahub.com/medical-information/selinexor-triplets-for-relapsedrefractory-multiple-myelomaan-alternative-to-imid-based-therapy
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind